Majid Rezaei Selected Research

Oxaliplatin (Eloxatin)

1/2022

Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Majid Rezaei Research Topics

Disease

1	Neoplasms (Cancer) 01/2022
1	Reperfusion Injury 01/2022
1	Vomiting 01/2022
1	Diarrhea 01/2022
1	Nausea 01/2022
1	Peripheral Nerve Injuries 03/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2020
1	Hemolysis 01/2020
1	Foreign-Body Reaction 10/2012

Drug/Important Bio-Agent (IBA)

1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	SuspensionsIBA 01/2022
1	mesoglycanIBA 03/2021
1	Cell Adhesion MoleculesIBA 02/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020
1	Uric Acid (Urate)IBA 02/2020
1	Biomarkers (Surrogate Marker)IBA 02/2020
1	C-Reactive ProteinIBA 02/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020

Therapy/Procedure

1	Transplantation 01/2022
1	Sutures (Suture) 10/2012